Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
NCT06963203 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 486
Last updated 2025-07-02
Summary
The goal of this observational study is to learn about the potential differences in morbidity of thyroidectomy (removal of the thyroid gland) depending on the preoperative hormonal status. The main question it aims to answer is:
Do patients undergoing thyroidectomy for thyreotoxicosis (thyroid hyperfunction) due to Graves' disease or Amiodarone induced thyreotoxicosis have comparable complication rates depending on their thyroid metabolic status prior or during the procedure.
The data from participants undergoing a thyroidectomy at one of the study sites will be prospectively registered in the EUROCRINE registry, including an add-on module for additional study specific routine data. The operation itself, the preoperative or postoperative treatments are not altered in any way.
Conditions
- Graves Disease
- Amiodarone-Induced Thyrotoxicosis
- Thyroidectomy
Sponsors & Collaborators
-
Spital Männedorf
collaborator UNKNOWN -
Spital Limmattal Schlieren
collaborator OTHER -
Centre Hospitalier Universitaire Vaudois
collaborator OTHER -
Ospedale Regionale di Mendrisio
collaborator OTHER -
Kantonsspital St. Gallen, Switzerland
collaborator UNKNOWN -
Cantonal Hosptal, Baselland
collaborator OTHER -
St. Claraspital AG
collaborator OTHER -
University Hospital, Geneva
collaborator OTHER -
Insel Gruppe AG, University Hospital Bern
collaborator OTHER -
ASZ Aalst
collaborator OTHER -
University Hospital Virgen de las Nieves
collaborator OTHER -
University of Nancy
collaborator OTHER -
Hospital Costa del Sol
collaborator OTHER -
Evgenidion Hospital Athens, Greece
collaborator UNKNOWN -
Andrea Goldmann
lead OTHER
Principal Investigators
-
Andrea Goldmann, MD · Kantonsspital Winterthur KSW
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-31
Countries
- Belgium
- France
- Greece
- Spain
- Switzerland
Study Locations
More Related Trials
-
Classic Total Thyroidectomy With or Without Drains
NCT00691990 ·Status: COMPLETED ·Phase: NA
-
ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy
NCT02973802 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
NCT07059507 ·Status: RECRUITING
-
Remission Induction and Sustenance in Graves' Disease 2
NCT00796913 ·Status: COMPLETED ·Phase: NA
-
A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy
NCT04776993 ·Status: RECRUITING ·Phase: PHASE3
-
Immediate Postoperative Course of Patients With Mini Video Assisted Total Thyroidectomy (miVAT) Versus Classic Total Thyroidectomy (cTT)
NCT00692835 ·Status: COMPLETED ·Phase: NA
-
Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
NCT04932135 ·Status: COMPLETED
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT06727604 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
Heart Rate Monitoring by Wearable Devices in Graves' Disease
NCT04333342 ·Status: UNKNOWN ·Phase: NA
-
Late Postoperative Course of Patients With Mini Video Assisted Thyroidectomy (miVAT) Versus Classic Thyroidectomy (T)
NCT00693147 ·Status: COMPLETED ·Phase: NA
-
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients
NCT03276988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323 ·Status: RECRUITING ·Phase: PHASE2
-
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
NCT07261345 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Coexisting Thyroid Disease and Hyperparathyroidism
NCT01306916 ·Status: COMPLETED
-
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
NCT01736163 ·Status: COMPLETED
-
Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care
NCT06327828 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Evaluation of OptiThyDose
NCT06864351 ·Status: RECRUITING ·Phase: NA
-
A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China
NCT07040306 ·Status: RECRUITING
-
Antithyroid Drugs During Radioiodine Therapy
NCT00150137 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose Radioiodine Ablation in Graves' Disease
NCT03110835 ·Status: COMPLETED
-
Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test After Total Thyroidectomy
NCT00793689 ·Status: COMPLETED
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
NCT05907668 ·Status: COMPLETED ·Phase: PHASE2